

(Sharecast News) - Biotherapeutics and reagents developer Avacta has received approval from the Medicines and Healthcare Products Regulatory Agency (M...


AIM WINNERS & LOSERS: Cornish Metals Jumps 40% On AIM Debut


Avacta Shares Surge On Positive Data For Covid-19 Antigen Test


(Sharecast News) - Biotherapeutics and reagents developer Avacta Group has received the first data for its SARS-CoV-2 rapid antigen test from ongoing ...


(Sharecast News) - Biotherapeutics developer Avacta Group has entered into a commercial partnership with Mologic, it announced on Monday, to accelerat...


AIM WINNERS & LOSERS: Bahamas Petroleum Sinks As Pulls Plug On Well


Avacta Signs Agreement With Mologic For AffiDX Covid-19 Antigen Test


TRADING UPDATES: Asiamet Hits Back At Shareholder; Hardide Raises Cash